New schizophrenia shot tested against established brand
NCT ID NCT07268430
Summary
This study tested whether a new monthly injection for schizophrenia works the same way in the body as an existing, approved injection. It involved 256 adults in China with stable schizophrenia who received either the new or the existing injection for several months. The main goal was to see if the two versions produced similar drug levels in the blood, which suggests they would have similar effectiveness and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Anding Hospital Capital Medical University
Beijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.